Clinical Trials Logo
  1. Home
  2. Neuralgia, Postherpetic
  3. NCT00614705

PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia

Neuralgia, Postherpetic Clinical Trial

Official title:
A Four Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2A Study Of PH-797804 In The Treatment Of Post-Herpetic Neuralgia

Clinical Trial Summary

This is a proof-of-concept study to determine if PH-797804 reduces neuropathic pain associated with post-herpetic neuralgia. Suitable patients will be randomized to receive either PH-797804 or placebo for 4 weeks, during which time they will also record their pain symptoms using various pain scales.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00614705
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 2
Start date April 2008
Completion date December 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT02484170 - Mannitol Cream for Post Herpetic Neuralgia Phase 1/Phase 2
Terminated NCT00964990 - A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia) Phase 2
Completed NCT00394901 - A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia Phase 3
Completed NCT01252160 - Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage Phase 4
Completed NCT00377598 - Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia Phase 2/Phase 3
Completed NCT00160667 - A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia) Phase 2
Terminated NCT00245544 - Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004) Phase 2
Completed NCT00335933 - Safety and Efficacy of Gabapentin in Postherpetic Neuralgia Phase 3
Completed NCT00617461 - A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment Phase 2
Withdrawn NCT02426411 - Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN Phase 2
Completed NCT01129531 - A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia Phase 2
Completed NCT00674687 - A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing N/A
Terminated NCT01678924 - A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia Phase 2
Completed NCT00424372 - A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia Phase 3
Completed NCT00619476 - A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN) Phase 2
Terminated NCT00295776 - Lamictal in the Treatment of Post-Herpetic Neuralgia Phase 2/Phase 3
Completed NCT00570310 - Neuropathic Pain Syndrome Patient Study (MK-0000-072) Phase 1
Terminated NCT00282763 - A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005) Phase 2
Completed NCT00568321 - RN624 For Pain Of Post-Herpetic Neuralgia Phase 2
Not yet recruiting NCT01102101 - Effect of Opioids in Neuropathic Pain in Postherpetic Patients Phase 3